PEAK-TROUGH examining:
Ultimately, I’m a believer in clinical observation rather than fancy and expensive lab tests.
I see zero rationale ever for decreasing a dose based on P-T levels. What counts is how the patient is doing - NOT what a lab experiment shows (identical reasoning for my disdain for urine tests!). The “clinic” insisted she have peak-trough blood concentration examining done - and pay for it! Patient’s dojng well on a dose, great. It’s when the dose gets up[ to 150-200 and the patient still reports doing poorly, particularly toward end of day, soon after logic dictates trial of splitting the dose - say half AM and half PM. My understanding: peak-trough relationship merely indicates that one might have a “fast metabolizer”. It’s indicated not to determine adequacy of dosage, but to help formulate response to patient discomfort and less than optimal therapeutic results. whether not, and most definitely whether patient has been getting dosage that for most is sub-optimal (e.g., less than 80) soon after of course increase the dose! In fact, increasing it in such
Tom Payte is the expert on that… We’ve been copied on correspondence involving a long-time methadone patient who has not been doing well on doses that very slowly and grudgingly were raised to about 80-mg per day. Thus: rationale for splitting doses - I’ve heard Tom Payte talk about some (very few) patients whom he had to give doses six times a day before they responded well.
If one has a patient not doing well, and there’s a big big gap amoung the peak concentration and the lowest in the course of a day, soon after it might produce much more sense to split the dose rather than “just” increase it. Based on the results they claim there’s no rationale for increasing the dosage and instead are threatening to decrease it.
Original post by RGNewman, MD
No comments yet. Be the first.
Leave a reply



















